NPCE · NeuroPace Inc · Proposed Sales
Market Cap
$481.91M
Shares
34.32M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-12-15 | MARTHA J MORRELL | Officer | 25,000 | 2025-12-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-01-30 | MARTHA J MORRELL | Officer | 78,534 | 2025-01-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-01-29 | MARTHA J MORRELL | Officer | 100 | 2025-01-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-01-24 | MARTHA J MORRELL | Officer | 3,200 | 2025-01-24 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-10-28 | KCK LTD. | 10% Stockholder | 223,991 | 2024-10-25 | Goldman Sachs & Co. LLC |
| 2024-10-03 | KCK LTD. | 10% Stockholder | 190,000 | 2024-08-30 | Goldman Sachs & Co. LLC |
| 2024-03-15 | Irina Ridley | Chief Legal Officer | 3,936 | 2024-03-15 | J.P. Morgan Securities LLC |
| 2023-12-20 | Martha Morrell | Chief Medical Officer | 48,397 | 2023-12-20 | J.P. Morgan Securities LLC |
| 2023-12-06 | Martha Morrell | Affiliate | 11,005 | 2023-12-06 | J.P. Morgan Securities LLC |
| 2023-11-29 | KCK Ltd. | Shareholder | 262,836 | 2023-11-27 | Goldman Sachs & Co. LLC |
| 2023-10-02 | OrbiMed Private Investments VI, LP | Shareholder | 288,100 | 2023-10-02 | JP Morgan Chase & Co. |
Showing 1–11 of 11 filings